Advertise | About Us | Contact Us

Article - Issue 64

AI is in Every Pharma Strategy Deck

Article - Issue 64

Maximising Patient Engagement in Clinical Trials

Article - Issue 64

Long-acting Injectable Formulations

Article - Issue 64

Why Sustainable Biomanufacturing Must Start Earlier in The Process

Article - Issue 64

Complex Journey from Innovation to Patient impact

EDITORIAL SECTIONS

Why X-ray Inspection is a Viable Quality Assurance Solution for Pharma Products

Adopting the Power of AI to Drug Development Projects

A tremendous amount of documentation is created throughout the clinical trial lifecycle

Real-world Evidence

Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA

Just in Time Manufacturing Creating more sustainable supply chains

Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine

Challenges and Advantages of Using Artificial Intelligence in Pharma

Many advanced largescale AI initiatives still need to be proved successful in Pharma

Advisory Board

Victor M. Diaz Perez

Brian D Smith

Nigel Cryer FRSC

Quang Bui

Tamara Miller

Imedla Leslie Rillon

Andri Kusandri

Nicoleta Grecu

Alessio Piccoli

Pramod Kashid

Neil J Campbell

Porton Pharma Solutions and Codexis Launch Global Partnership

PARTNERSHIP
Codexis Inc and Porton Pharma Solutions Ltd announce a strategic collaboration to deploy Codexis worldleading biocatalyst technology within Portons global custom intermediate and active pharmaceutical ingredients API development and manufacturing business The partnership will accelerate the creation and commercialization of new lowcost sustainable manufacturing processes exploiting the benefits of...

Articles

Novel Developments in Drug Delivery Systems

Discovery of new active pharmaceutical compounds is no longer the only essential factor for therapeutic innovation clinical success increasingly depends on how effectively those agents are delivered to the intended site of action

Research Insights

An Expandable Synthetic Library of Human Paired Antibody Sequences

The potential diversity in the global repertoire of human antibody sequences is currently not well understood due to the limited existing paired antibody heavylight chain sequence data that has been hindered by the low throughput and high costs of current

Case Studies

Regulating Pharmaceutical Industry Marketing: Development, Enforcement And Outcome Of Marketing Rules: A Case Study By Lund University

Abstract This essay studies work in sociology and cognate fields regarding pharmaceutical marketing and its regulation In particular it considers how this literature contributes to a better understanding of the process of pharmaceuticalization defined as the translation or transformation of human conditions capabilities and capacities into opportuni

Techno Trends

Janssen Pharmaceutical Discovered First-of-its-Kind ERLEADA® (apalutamide)

The Janssen Pharmaceutical Companies of Johnson Johnson discovered firstofitskind ERLEADA apalutamide for the treatment of patients with nonmetastatic castrationresistant prostate cancer nmCRPC and for the treatment of patients with metastatic castrationsensitive prostate cancer mCSPC

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

Design of Self-antibacterial and Biocompatible Titanium Surfaces for Biomedical Applications

Lalit M. Pandey

Lalit M Pandey is an Associate Professor at the Department of Biosciences and Bioengineering, IIT Guwahati. His main research interests include biointerfaces and biomaterials, biochemical engineering, and environmental biotechnology. He has published over hundred research articles in international journals and serves on the editorial board of six international journals. He is serving as Associate Editor in Frontiers in Bioengineering and Biotechnology. He has co-edited three books. He is a life member of the International Association of Engineers (IAENG), the National Academy of Sciences (NASI), the Indian Institute of Chemical Engineers (IIChE), the Biotech Research Society, India (BRSI), and Nano and Molecular Society (India) and serves as a reviewer for several peer-reviewed journals.

Alpha-fetoprotein as a Shuttle for Medicines

Vladimir N Pak

Vladimir Pak received his Ph.D. from the Institute of Bioorganic Chemistry, Moscow. He modernized technologies and manufactured APIs for the known drugs. Invented anticancer drug candidates based on alpha-fetoprotein that can be used as injectable or orally. Developed supplements to treat stomach ulcers and IBD.

Therapeutic Peptides

Rienzi Mosqueda

Rienzi Mosqueda is a dedicated writer specialising in life science, health, and pharma content. With a passion for clear, engaging writing, Rienzi provides fresh perspectives on each topic. His ability to simplify complex ideas makes the articles valuable for readers of all backgrounds. As an emerging voice, Rienzi Mosqueda is committed to sharing knowledge and sparking discussions through their impactful writing.

Blockchain for Data Integrity in Biopharma

Reshma Kodumuru

Reshma Kodumuru is a Computer System Validation (CSV) leader at KBI Biopharma with expertise in data integrity and regulatory compliance. She specialises in designing and implementing validation frameworks that enhance operational efficiency within the biopharmaceutical industry, bridging complex data systems with strategic, compliant, and effective business solutions.

Envisioning the Biomanufacturing Facility of the Future

Merrilee Whitney

Merrilee is the Head of the BioContinuum™ Platform, driving the strategy and execution of Process Intensification Technologies, Software & Automation, and Analytics to meet the needs of biologics manufacturers. Throughout her 15 years at MilliporeSigma, she managed multiple product lines including clarification, aseptic, virus filtration, and Single Use & Systems.

INDUSTRY UPDATES

press releasesRead more...

EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease

EpiSign Inc and Geneyx Genomex Ltd today announced a partnership to advance the integration of genomic and epigenomic analysis for raredisease interpretation

Aptar Pharma Launches Premia™ Precision, a New Quality Standard for Demanding Injectable Therapies

Aptar Pharma a global leader in drug delivery dosing protection technologies and services today announced the launch of Premia Precision a new quality standard for elastomer components

Italfarmaco and VeriSIM Life Partner to Develop Novel HDAC-Targeting Therapeutics for Neuromuscular, Fibrotic, and Rare Diseases

Italfarmaco SpA a global pharmaceutical company with established expertise in histone deacetylase HDAC biology and therapeutic development and VeriSIM Life an AIenabled drug discovery and development

Fujifilm Installs Manufacturing Equipment for Antibody-Drug Conjugate (ADC) Components at Hirono Plant

FUJIFILM Corporation announced it will install manufacturing equipment for linkerpayloads ADC components at the Hirono Plant Hironomachi Futabagun Fukushima Prefecture which is operated

Biomapas Acquires Pinnaxis, Strengthening Its Pharmacovigilance Technology Expertise

Biomapas a leading integrated life sciences services provider announces the acquisition of Pinnaxis a global pharmacovigilance technology and consulting company headquartered in Noida India specialising

Sanofi and 2026 NBA Champion Karl-Anthony Towns team up to raise awareness of COVID-19 vaccination with NUVAXOVID®

Sanofi has partnered with NBA Champion KarlAnthony Towns to help raise awareness about the importance of COVID vaccination among those eligible during the respiratory season